Skip to main content

Technology

HIMSS24
By HIMSS TV | 05:00 pm | June 04, 2024
Dr. John Showalter, Linus' chief product officer, discusses the company's cognitive impairment testing and care-delivery offerings for dementia diagnosis and treatment and its acquisition of speech analytics platform Aural Analytics.  
By Nathan Eddy | 11:28 am | June 04, 2024
The virtual care services provider's tools will be embedded into League's offerings and add secure chat and multipoint care navigation to its portfolio.
By Jessica Hagen | 04:00 pm | June 03, 2024
Cancer patients and caregivers will receive free access to an AI-enabled app for mental health and other support services.
By Jessica Hagen | 02:10 pm | June 03, 2024
CasePointer's workforce will join Deloitte, and the company will use the business's software in conjunction with its GovConnect assets to assist its government clients.
By Jessica Hagen | 02:38 pm | May 31, 2024
The investment comes less than a year after the company launched with $9 million in funding, bringing its total raise to more than $25 million.
By Jessica Hagen | 02:07 pm | May 31, 2024
The publicly traded company, which announced it was seeking strategic alternatives for its business last month, will go private thanks to the merger.
HIMSS24
By HIMSS TV | 05:08 pm | May 30, 2024
Dr. Michal Tzuchman Katz, cofounder and CEO of Kahun, discusses how educating doctors on the source of information for the company's clinical knowledge graph and how the product supports patient care encourage its adoption.  
By Jessica Hagen | 03:40 pm | May 29, 2024
A study published in Clinical Imaging says ChatGPT can simplify radiology reports, but the results differ significantly based on racial context.
By HIMSS TV | 07:00 am | May 28, 2024
Ansys industry director for Healthcare Solutions Thierry Marchal and researcher María Angeles Pérez discuss how combining clinical data and mathematical models can increase precision and expedite treatment plans.  
By Jessica Hagen | 04:13 pm | May 24, 2024
The continuous glucose monitoring biosensor platform will use the funds to scale its manufacturing, move toward regulatory approval and perform more clinical trials.